Organization
Sutton
2 abstracts
Abstract
Health-related quality of life and pain in a phase 3 study of [177Lu]Lu-PSMA-617 in taxane-naïve patients with metastatic castration-resistant prostate cancer (PSMAfore).Org: Memorial Sloan Kettering Cancer Center, Carolina Urologic Research Center and GenesisCare US, British Columbia Cancer Agency (BCCA), Veterans Prostate Cancer Awareness, Novartis Pharmaceuticals Corporation,
Abstract
B-LYMPHOCYTE FUNCTION IS ALTERED BY PROTEASE ACTIVATED RECEPTOR-1 Org: Sutton, Laboratory of Tissue Engineering, Institute of Bone and Joint Research, Sydney, Kolling Institute, University of Sydney and Sydney Cancer Centre,